Tacrolimus

cytochrome P450 family 4 subfamily F member 3 ; Homo sapiens







13 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34620272 Tacrolimus and herbs interactions: a review. 2021 Oct 1 2
2 25162212 Interleukin-2 receptor antagonist therapy leads to increased tacrolimus levels after kidney transplantation. 2015 Apr 2
3 25850753 Supra-therapeutic tacrolimus concentrations associated with concomitant nicardipine in pediatric liver transplant recipients. 2015 Jun 1
4 18493655 Bifunctional molecules evade cytochrome P(450) metabolism by forming protective complexes with FK506-binding protein. 2008 Jun 1
5 17190370 Influence of ABCB1 C3435T polymorphism on the pharmacokinetics of lansoprazole and gastroesophageal symptoms in Japanese renal transplant recipients classified as CYP2C19 extensive metabolizers and treated with tacrolimus. 2006 Dec 2
6 15244495 Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. 2004 2
7 11392178 Acute tacrolimus overdose and treatment with phenytoin in liver transplant recipients. 2001 Apr 1
8 11144010 Hypothyroidism as a cause of tacrolimus intoxication and acute renal failure: a case report. 2000 Nov 10 2
9 8689938 Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability. 1995 Dec 4
10 8750397 Drug interactions in transplantation. 1995 Nov-Dec 1
11 16535142 Microbial Demethylation of Immunosuppressant FK-506: Isolation of 31-O-FK-506-Specific Demethylase Showing Cytochrome P-450 Characteristics from Streptomyces rimosus MA187. 1995 Oct 1
12 1385058 Cytochrome P-450 3A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat. 1992 Sep-Oct 3
13 1721276 Effects of FK 506 on human hepatic microsomal cytochrome P-450-dependent drug metabolism in vitro. 1991 Dec 1